Industry
Sionna and Odyssey Therapeutics Kick Off 2025 Biotech IPO Wave with SEC Filings
Sionna Therapeutics, Odyssey Therapeutics, IPO filings, biotech industry, JPM Healthcare Conference, 2025 IPO market
Key Takeaways from #JPM25: Strategic Partnerships and Acquisitions Dominate the JP Morgan Healthcare Conference
JP Morgan Healthcare Conference, #JPM25, biopharma industry, acquisitions, partnerships, Eli Lilly, Zealand Pharma, GSK, Scorpion Therapeutics
IGM Biosciences Halts Autoimmune Projects Amid Layoffs Following Disappointing Trial Data
IGM Biosciences, layoffs, autoimmune diseases, bispecific antibody T cell engagers, imvotamab, IGM-2644, biotech industry
Revance Therapeutics Faces Competing Buyout Offers: Teoxane SA Outbids Crown Laboratories
Revance Therapeutics, Teoxane SA, Crown Laboratories, buyout offers, merger agreement, biotechnology, skincare industry
Javara Undergoes Restructuring, Lays Off Staff Amidst Industry-Wide Challenges
Javara, layoffs, restructuring, clinical research, biopharma industry challenges
Ring Therapeutics Undergoes Significant Restructuring, Laying Off Nearly Half of Its Workforce
Ring Therapeutics, layoffs, workforce reduction, biotech industry, restructuring
Editas Medicine Undergoes Major Restructuring, Cutting 65% of Staff and Halting Sickle Cell Therapy Development
Editas Medicine, layoffs, restructuring, sickle cell therapy, CRISPR gene editing, biotech industry
Walgreens Boots Alliance in Negotiations for Potential Sale to Private Equity Firm Sycamore Partners
Walgreens Boots Alliance, Sycamore Partners, private equity sale, retail industry, healthcare retail
Belharra Biotech Cuts 21 Jobs Amid Industry-Wide Restructuring
Belharra Biotech, layoffs, chemoproteomics, biotech industry, restructuring
Belharra Therapeutics Reduces Workforce by 40%, Laying Off 21 Employees
Belharra Therapeutics, layoffs, workforce reduction, biotech industry, drug discovery